Abstract
Duplicate antimicrobial susceptibility test results were reviewed over a 1-year period to determine whether repeat testing of sequential isolates with the same identification from the same patient and specimen site was necessary. In our institution, repeat testing is always needed for coagulase-negative staphylococci and Pseudomonas aeruginosa and is needed after 3 days for members of the family Enterobacteriaceae, but it is not routinely necessary for Staphylococcus aureus.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bartlett R. C. Making optimum use of the microbiology laboratory. III. Aids of antimicrobial therapy. JAMA. 1982 Apr 2;247(13):1868–1871. [PubMed] [Google Scholar]
- Jones R. N., Edson D. C. Interlaboratory performance of disk agar diffusion and dilution antimicrobial susceptibility tests, 1979-1981. A summary of the microbiology portion of the College of American Pathologists (CAP) surveys. Am J Clin Pathol. 1982 Oct;78(4 Suppl):651–658. [PubMed] [Google Scholar]
- Lowy F. D., Hammer S. M. Staphylococcus epidermidis infections. Ann Intern Med. 1983 Dec;99(6):834–839. doi: 10.7326/0003-4819-99-6-834. [DOI] [PubMed] [Google Scholar]
- Milatovic D., Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol. 1987 Jun;6(3):234–244. doi: 10.1007/BF02017607. [DOI] [PubMed] [Google Scholar]
- Salata R. A., Lederman M. M., Shlaes D. M., Jacobs M. R., Eckstein E., Tweardy D., Toossi Z., Chmielewski R., Marino J., King C. H. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis. 1987 Feb;135(2):426–432. doi: 10.1164/arrd.1987.135.2.426. [DOI] [PubMed] [Google Scholar]
- Sanders C. C., Sanders W. E., Jr Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis. 1983 Jul-Aug;5(4):639–648. doi: 10.1093/clinids/5.4.639. [DOI] [PubMed] [Google Scholar]
- Seale T. W., Thirkill H., Tarpay M., Flux M., Rennert O. M. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients. J Clin Microbiol. 1979 Jan;9(1):72–78. doi: 10.1128/jcm.9.1.72-78.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sheehan D. J., Janda J. M., Bottone E. J. Pseudomonas aeruginosa: changes in antibiotic susceptibility, enzymatic activity, and antigenicity among colonial morphotypes. J Clin Microbiol. 1982 May;15(5):926–930. doi: 10.1128/jcm.15.5.926-930.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sugarman B., Pesanti E. Treatment failures secondary to in vivo development of drug resistance by microorganisms. Rev Infect Dis. 1980 Mar-Apr;2(2):153–168. doi: 10.1093/clinids/2.2.153. [DOI] [PubMed] [Google Scholar]
- Thornsberry C., Gavan T. L., Sherris J. C., Balows A., Matsen J. M., Sabath L. D., Schoenknecht F., Thrupp L. D., Washington J. A., 2nd Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother. 1975 Apr;7(4):466–480. doi: 10.1128/aac.7.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]